Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 9/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.42 |
| ▸ | POLB | P06746 | 3/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12000061 | 0.92 | KDM4E (0.38) | MEN1KMT2AL3MBTL1KDM4ELMNA | |
| SCHEMBL2797961 | 0.91 | KCNH2 (0.41) | KCNH2 | |
| SCHEMBL2799830 | 0.90 | MEN1 (0.41) | MEN1KMT2APOLBKCNH2L3MBTL1 | |
| SCHEMBL12002168 | 0.89 | KCNH2 (0.46) | MEN1KMT2APOLBKCNH2 | |
| SCHEMBL2797883 | 0.88 | POLB (0.49) | MEN1KMT2APOLBL3MBTL1KDM4E | |
| SCHEMBL4136776 | 0.87 | KDM4E (0.40) | MEN1KMT2AL3MBTL1KDM4ELMNA | |
| SCHEMBL12002303 | 0.85 | KCNH2 (0.37) | KCNH2 | |
| SCHEMBL2796445 | 0.85 | POLB (0.45) | MEN1KMT2APOLBL3MBTL1LMNA | |
| SCHEMBL4136902 | 0.84 | ALDH1A1 (0.41) | MEN1KMT2AL3MBTL1KDM4EMAPK1 | |
| SCHEMBL12000067 | 0.82 | KCNH2 (0.33) | KMT2AKCNH2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8524738-B2 | Quinolinones and quinoxalinones as antibacterial composition | TOYAMA CHEMICAL CO., LTD. (JP) | 2013-09-03 | — | — | US | disclosed |
| US-8524738-B2 | Quinolinones and quinoxalinones as antibacterial composition | TOYAMA CHEMICAL CO., LTD. (JP) | 2013-09-03 | — | — | US | disclosed |
| US-8329694-B2 | Quinoxalinones as antibacterial composition | TOYAMA CHEMICAL CO., LTD. (JP) | 2012-12-11 | — | — | US | disclosed |
| US-8329694-B2 | Quinoxalinones as antibacterial composition | TOYAMA CHEMICAL CO., LTD. (JP) | 2012-12-11 | — | — | US | disclosed |
| US-20120214990-A1 | QUINOLINONES AND QUINOXALINONES AS ANTIBACTERIAL COMPOSITION | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2012-08-23 | — | — | US | disclosed |
| US-20120210937-A1 | SUBSTRATE PROCESSING APPARATUS USING A BATCH PROCESSING CHAMBER | APPLIED MATERIALS, INC. (US) | 2012-08-23 | — | — | US | disclosed |
| EP-2468743-A1 | Nitrogen-containing bicyclic compounds useful as antibacterial agents | Toyama Chemical Co., Ltd. (JP) | 2012-06-27 | — | — | EP | disclosed |
| CN-101061253-B | Substrate processing apparatus using batch processing chamber | APPLIED MATERIALS INC | 2010-12-22 | — | — | CN | disclosed |
| US-20100173495-A1 | SUBSTRATE PROCESSING APPARATUS USING A BATCH PROCESSING CHAMBER | APPLIED MATERIALS, INC. | 2010-07-08 | — | — | US | disclosed |
| US-20100168418-A1 | NOVEL NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2010-07-01 | — | — | US | disclosed |
| EP-1900732-A1 | NOVEL NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2008-03-19 | — | — | EP | disclosed |
| CN-101061253-A | Substrate processing apparatus using batch processing chamber | APPLIED MATERIALS INC (US) | 2007-10-24 | — | — | CN | disclosed |
| US-7279392-B2 | Thin film structure, capacitor, and methods for forming the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2007-10-09 | — | — | US | disclosed |
| EP-1824960-A2 | SUBSTRATE PROCESSING APPARATUS USING A BATCH PROCESSING CHAMBER | Applied Materials, Inc. (US) | 2007-08-29 | — | — | EP | disclosed |
| US-7151039-B2 | Method of forming oxide layer using atomic layer deposition method and method of forming capacitor of semiconductor device using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2006-12-19 | — | — | US | disclosed |
| US-20060156979-A1 | Substrate processing apparatus using a batch processing chamber | APPLIED MATERIALS, INC. | 2006-07-20 | — | — | US | disclosed |
| WO-2006055984-A2 | SUBSTRATE PROCESSING APPARATUS USING A BATCH PROCESSING CHAMBER | APPLIED MATERIALS, INC. (US) | 2006-05-26 | — | — | WO | disclosed |
| US-20050170566-A1 | Thin film structure, capacitor, and methods for forming the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2005-08-04 | — | — | US | disclosed |
| US-20050170601-A1 | Methods of forming dielectric structures and capacitors | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2005-08-04 | — | — | US | disclosed |
| US-20040033698-A1 | Method of forming oxide layer using atomic layer deposition method and method of forming capacitor of semiconductor device using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2004-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168418-A1 | NOVEL NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF | ROS1, NOX1, ARG1 | MEN1 1971/4885KMT2A 1173/4885POLB 2770/4885 |
| US-20120214990-A1 | QUINOLINONES AND QUINOXALINONES AS ANTIBACTERIAL COMPOSITION | NQO2, ASNS, NDUFS1 | MEN1 2461/4885KMT2A 2354/4885POLB 314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.